|
⚲
|
| Keyboard |
| Jason Rhodes | |
|---|---|
| Firm | Atlas Venture Life Science Advisors LLC |
| Address | c/o Atlas Venture Life Science Advisors 300 Technology Square, 8th Floor Cambridge, MA 02139 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors LLC | |||||
| Atlas Venture Opportunity Fund III LP | 021-556589 | Executive Officer | 400.0 M of 400.0 M |
399.0 M | |
| Atlas Venture Fund XIV LP | 021-531177 | Executive Officer | 450.0 M of 450.0 M |
452.0 M | |
| Atlas Venture Fund XIII LP | 021-435762 | Executive Officer | 450.0 M of 450.0 M |
551.4 M | |
| Atlas Venture Opportunity Fund II LP | 021-415392 | Executive Officer | 300.0 M of 300.0 M |
287.4 M | |
| Atlas Venture Fund XII LP | 021-368325 | Executive Officer | 400.0 M of 400.0 M |
318.2 M | |
| Atlas Venture Opportunity Fund I LP | 021-326809 | Executive Officer | 250.0 M of 250.0 M |
164.0 M | |
| Atlas Venture Fund Xi LP | 021-289898 | Executive Officer | 350.0 M of 350.0 M |
340.2 M | |
| Atlas Venture Fund X LP | 021-230375 | Executive Officer | of 250.0 M |
490.8 M | |
| Dyne Therapeutics Inc | 021-373216 | Director | 115.7 M of 115.7 M |
||
| Generation Bio Co | 021-357901 | Director | 111.5 M of 111.5 M |
||
| Generation Bio Co | 021-306954 | Director | 100.4 M of 100.4 M |
||
| Gemini Therapeutics Inc | 021-262383 | Director | 2.0 M of 2.0 M |
||